[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.191.145. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 20, 1925

THE TREATMENT OF AMEBIASIS BY ORAL ADMINISTRATION OF STOVARSOL: (ACETYLAMINOHYDROXYPHENYLARSONIC ACID)

Author Affiliations

NEW ORLEANS
From the Department of Medicine, Tulane University School of Medicine.

JAMA. 1925;84(25):1913-1914. doi:10.1001/jama.1925.02660510029009
Abstract

The publication by Marchoux 1 of the Pasteur Institute, in February, 1923, of the discovery of the specific amebicidal property of a new synthetic arsenical designed by Levaditi and his co-workers2 and the subsequent confirmation of this finding by other French investigators, notably Garin and Lepine,3 led us to investigate the properties of this drug. In a previous paper, we 4 published observations in a number of cases of amebic dysentery which confirmed the clinical results obtained by Marchoux. Our purpose in this communication is to record further observations in a large number of cases and the results of the treatment of those cases that we have been able to follow for a sufficient length of time to determine, to a limited extent, the curative effect of the plan of treatment employed with this drug.

Our observation of the results of treatment with stovarsol in forty-six patients has

×